GUARDIAN PHRMCY SERVICES-A (GRDN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:GRDN - US40145W1018 - Common Stock
30.98 USD
+0.24 (+0.78%)
30.98 USD
0 (0%)
GRDN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. GRDN has only an average score on both its financial health and profitability. GRDN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year GRDN was profitable.
GRDN had a positive operating cash flow in the past year.
GRDN had positive earnings in 4 of the past 5 years.
GRDN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
GRDN has a Return On Assets of 10.32%. This is amongst the best in the industry. GRDN outperforms 93.07% of its industry peers.
GRDN's Return On Equity of 21.90% is amongst the best of the industry. GRDN outperforms 88.12% of its industry peers.
GRDN's Return On Invested Capital of 20.33% is amongst the best of the industry. GRDN outperforms 92.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.32% | ||
| ROE | 21.9% | ||
| ROIC | 20.33% |
ROA(3y)-3.89%
ROA(5y)0.88%
ROE(3y)30.17%
ROE(5y)42.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 2.90%, GRDN is in the better half of the industry, outperforming 65.35% of the companies in the same industry.
The Operating Margin of GRDN (4.22%) is comparable to the rest of the industry.
With a Gross Margin value of 19.74%, GRDN perfoms like the industry average, outperforming 42.57% of the companies in the same industry.
GRDN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.22% | ||
| PM (TTM) | 2.9% | ||
| GM | 19.74% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.64%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so GRDN is creating value.
The number of shares outstanding for GRDN has been increased compared to 1 year ago.
GRDN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, GRDN has an improved debt to assets ratio.
2.2 Solvency
GRDN has an Altman-Z score of 10.00. This indicates that GRDN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 10.00, GRDN belongs to the top of the industry, outperforming 95.05% of the companies in the same industry.
There is no outstanding debt for GRDN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 10 |
ROIC/WACC2.25
WACC9.02%
2.3 Liquidity
A Current Ratio of 1.22 indicates that GRDN should not have too much problems paying its short term obligations.
GRDN has a Current ratio of 1.22. This is comparable to the rest of the industry: GRDN outperforms 43.56% of its industry peers.
A Quick Ratio of 0.93 indicates that GRDN may have some problems paying its short term obligations.
The Quick ratio of GRDN (0.93) is worse than 71.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.93 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 139.38% over the past year.
Looking at the last year, GRDN shows a very negative growth in Revenue. The Revenue has decreased by -28.22% in the last year.
The Revenue has been growing by 11.96% on average over the past years. This is quite good.
EPS 1Y (TTM)139.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.5%
Revenue 1Y (TTM)-28.22%
Revenue growth 3Y15.75%
Revenue growth 5Y11.96%
Sales Q2Q%20.05%
3.2 Future
GRDN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.28% yearly.
The Revenue is expected to grow by 9.16% on average over the next years. This is quite good.
EPS Next Y164.44%
EPS Next 2Y66.58%
EPS Next 3Y42.28%
EPS Next 5YN/A
Revenue Next Year17.72%
Revenue Next 2Y8.76%
Revenue Next 3Y9.16%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 49.17, GRDN can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of GRDN is on the same level as its industry peers.
GRDN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.84.
Based on the Price/Forward Earnings ratio of 32.66, the valuation of GRDN can be described as expensive.
GRDN's Price/Forward Earnings is on the same level as the industry average.
GRDN's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.17 | ||
| Fwd PE | 32.66 |
4.2 Price Multiples
GRDN's Enterprise Value to EBITDA is on the same level as the industry average.
GRDN's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.77 | ||
| EV/EBITDA | 23.74 |
4.3 Compensation for Growth
GRDN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of GRDN may justify a higher PE ratio.
A more expensive valuation may be justified as GRDN's earnings are expected to grow with 42.28% in the coming years.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y66.58%
EPS Next 3Y42.28%
5. Dividend
5.1 Amount
No dividends for GRDN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
30.98
+0.24 (+0.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners83.31%
Inst Owner Change8.08%
Ins Owners3.92%
Ins Owner Change74.94%
Market Cap1.96B
Revenue(TTM)1.39B
Net Income(TTM)40.24M
Analysts86
Price Target34.68 (11.94%)
Short Float %5.89%
Short Ratio4.03
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.47%
Min EPS beat(2)-13.49%
Max EPS beat(2)-11.45%
EPS beat(4)1
Avg EPS beat(4)-7.59%
Min EPS beat(4)-18.3%
Max EPS beat(4)12.89%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.42%
Min Revenue beat(2)2.36%
Max Revenue beat(2)4.48%
Revenue beat(4)3
Avg Revenue beat(4)1.77%
Min Revenue beat(4)-0.25%
Max Revenue beat(4)4.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)24.39%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.95%
EPS NY rev (1m)15.42%
EPS NY rev (3m)8.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.57%
Revenue NY rev (1m)2.73%
Revenue NY rev (3m)2.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.17 | ||
| Fwd PE | 32.66 | ||
| P/S | 1.41 | ||
| P/FCF | 28.77 | ||
| P/OCF | 22.29 | ||
| P/B | 10.68 | ||
| P/tB | 23 | ||
| EV/EBITDA | 23.74 |
EPS(TTM)0.63
EY2.03%
EPS(NY)0.95
Fwd EY3.06%
FCF(TTM)1.08
FCFY3.48%
OCF(TTM)1.39
OCFY4.49%
SpS21.95
BVpS2.9
TBVpS1.35
PEG (NY)0.3
PEG (5Y)N/A
Graham Number6.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.32% | ||
| ROE | 21.9% | ||
| ROCE | 25.73% | ||
| ROIC | 20.33% | ||
| ROICexc | 24.2% | ||
| ROICexgc | 49.8% | ||
| OM | 4.22% | ||
| PM (TTM) | 2.9% | ||
| GM | 19.74% | ||
| FCFM | 4.91% |
ROA(3y)-3.89%
ROA(5y)0.88%
ROE(3y)30.17%
ROE(5y)42.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.64%
F-Score6
Asset Turnover3.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 91.13% | ||
| Cap/Sales | 1.43% | ||
| Interest Coverage | 75.25 | ||
| Cash Conversion | 109.39% | ||
| Profit Quality | 169.42% | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.93 | ||
| Altman-Z | 10 |
F-Score6
WACC9.02%
ROIC/WACC2.25
Cap/Depr(3y)87.95%
Cap/Depr(5y)73.67%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)139.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%107.5%
EPS Next Y164.44%
EPS Next 2Y66.58%
EPS Next 3Y42.28%
EPS Next 5YN/A
Revenue 1Y (TTM)-28.22%
Revenue growth 3Y15.75%
Revenue growth 5Y11.96%
Sales Q2Q%20.05%
Revenue Next Year17.72%
Revenue Next 2Y8.76%
Revenue Next 3Y9.16%
Revenue Next 5YN/A
EBIT growth 1Y251.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year264.98%
EBIT Next 3Y58.03%
EBIT Next 5YN/A
FCF growth 1Y-26.08%
FCF growth 3Y-5.46%
FCF growth 5Y-0.01%
OCF growth 1Y-18.16%
OCF growth 3Y-0.31%
OCF growth 5Y0.63%
GUARDIAN PHRMCY SERVICES-A / GRDN FAQ
Can you provide the ChartMill fundamental rating for GUARDIAN PHRMCY SERVICES-A?
ChartMill assigns a fundamental rating of 5 / 10 to GRDN.
Can you provide the valuation status for GUARDIAN PHRMCY SERVICES-A?
ChartMill assigns a valuation rating of 4 / 10 to GUARDIAN PHRMCY SERVICES-A (GRDN). This can be considered as Fairly Valued.
Can you provide the profitability details for GUARDIAN PHRMCY SERVICES-A?
GUARDIAN PHRMCY SERVICES-A (GRDN) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for GRDN stock?
The Price/Earnings (PE) ratio for GUARDIAN PHRMCY SERVICES-A (GRDN) is 49.17 and the Price/Book (PB) ratio is 10.68.
Can you provide the expected EPS growth for GRDN stock?
The Earnings per Share (EPS) of GUARDIAN PHRMCY SERVICES-A (GRDN) is expected to grow by 164.44% in the next year.